Frontier Medicines
Pioneers in boldly advancing science
- Headquarters
- San Francisco, California
- Employees
- 51–200
- Founded
- 2019
- Business Model
- B2B
- Website
- frontiermedicines.com
- Total Funding
- $255.5M
- Last Round
- $20.0M Extension RoundJun 2024
About
Frontier Medicines is a clinical-stage precision medicine company pioneering covalent small-molecule drug discovery against previously undruggable targets. Its Frontier Platform combines chemoproteomics with machine learning to identify novel covalent binding sites across the proteome. The company has advanced multiple oncology development candidates and holds partnerships with major biopharma companies including AbbVie.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account